Skip Navigation



NDT Advance Access published online on May 14, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn266
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gfn266v3    most recent
gfn266v2
gfn266v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schmidt, S.
Right arrow Articles by Giet, M. v. d.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, S.
Right arrow Articles by Giet, M. v. d.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



The uraemic toxin phenylacetic acid impairs macrophage function

Sven Schmidt1, Timm H. Westhoff1, Philipp Krauser1, Ralf Ignatius2, Joachim Jankowski1, Vera Jankowski1, Walter Zidek1 and Markus van der Giet1

1 Charité Centrum 10-Nephrology 2 Institut für Mikrobiologie und Hygiene, Charité-Campus Benjamin Franklin, Berlin, Germany

Correspondence and offprint requests to: Sven Schmidt, Charité-Campus Benjamin Franklin, Charité Centrum 10-Nephrology, Hindenburgdamm 30, Berlin 12200, Germany. Tel: +49-30-8445-2217; Fax: +49-30-8445-4235; E-mail: s.schmidt{at}charite.de



  Abstract

Background. Nitric oxide (NO) is known to be an important mediator of macrophage cytotoxicity. NO in macrophages is generated via the inducible nitric oxide synthases (iNOS). Macrophage dysfunction is an important contributory factor for the increased incidence of infections in uraemia. Recently, we identified phenylacetic acid (PAA) as a novel uraemic toxin in patients on regular haemodialysis. PAA inhibits iNOS expression. In the present study, we investigated the impact of PAA on macrophage function.

Methods. RAW 264.7 cells were stimulated by LPS/IFN-{gamma} in the absence and presence of PAA. iNOS mRNA was determined by real-time PCR, iNOS protein was examined by western blotting and the NO degradation product, nitrite, by Griess assay. Macrophage phagocytosis was assessed by FACS and fluorescence microscopy. Further we quantified the cytotoxicity against intracellular bacteria (Salmonella typhimurium) by a macrophage-killing assay. ELISA and Bioplex protein array system was used for the investigation of iNOS second messenger pathways (NF-{kappa}B, ERK1/2, JNK and p38MAPK). iNOS mRNA half-lifetime in the presence or absence of PAA was determined by real-time PCR.

Results. PAA significantly inhibits iNOS mRNA induction in RAW 264.7 cells by LPS/IFN-{gamma} [6 h: LPS/IFN-{gamma}-stimulation: 100%; LPS/IFN-{gamma}-stimulation/PAA (1 mM): 68 ± 7%] at concentrations comparable to those of patients on chronic haemodialysis. iNOS protein expression and nitrite formation in RAW 264.7 cells were significantly inhibited by PAA. iNOS mRNA half-lifetime was not affected by PAA. The phagocytic activity of RAW 264.7 was not significantly affected by PAA, whereas the cytotoxicity against intracellular bacteria was significantly reduced. Analysis of the iNOS signal transduction pathways provided evidence that activation of the mitogen-activated kinases ERK1/2 and JNK is significantly blocked by PAA, whereas activation of p38MAPK is unaffected. The NF-{kappa}B pathway was not affected by PAA.

Conclusions. The present findings show that the uraemic toxin PAA has inhibitory effects on macrophage-killing function, which are mediated by inhibitory effects on transcriptional iNOS regulation. iNOS inhibition by PAA might affect immunoregulatory processes and could play a role in aggravation of immunodeficiency of patients with end-stage renal disease.

Keywords: iNOS; macrophage function; phenylacetic acid; uraemic toxin

Received for publication: 5.11.07
Accepted in revised form: 17. 4.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.